REFILE-TABLE-AnGes MG -9-MTH group results

Mon Oct 28, 2013 2:55am EDT

Related Topics

(Adds company forecast)
Oct 28 (Reuters)- 
             AnGes MG Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2013        Sep 30, 2012     Dec 31, 2013 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            391 mln             362 mln         450 mln - 550 mln            
                 (+8.1 pct)         (+104.5 pct)                  
  Operating     loss 946 mln          loss 1.36      loss 1.40 - loss 1.20             
  Recurring     loss 946 mln          loss 1.26      loss 1.40 - loss 1.20                 
  Net           loss 971 mln          loss 1.25      loss 1.45 - loss 1.25              
  EPS         loss 3,278.26 yen   loss 4,989.02 yen  loss 4,824.82 yen - loss 4,159.32 yen      
      
  Ann Div                                nil              nil     
  -Q2 div            nil                 nil                      
  -Q4 div                                nil              nil     
  NOTE - AnGes MG Inc is engaged in research and development of pharmaceutical products. 
  For latest earnings estimates made by Toyo Keizai, please double click on. 
  

 (Reporting By Michiko Kawai)
FILED UNDER: